4th Quarter - Report
SIMS STRATEGIES, LLC for GLAXOSMITHKLINE, INC.
Firm
Client
Income
$40,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Drug cost and pricing policy issues. S. 2543, the Prescription Drug Pricing Reduction Act. S. 1895, the Lower Health Care Costs Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD PRETTYMAN | Legislative Correspondent and Constituent Services Representative, Sen. Tom Carper (D-DE) |
| MICHAELA SIMS | Legislative Counsel, Sen. Ben Nelson (D-NE); Legislative Director and Counsel, Sen. Bob Kerrey (D-NE) |
Pharmacy PHA
Education and importance of various pharmaceutical industry issues, including issues affecting vaccines and shortages.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD PRETTYMAN | Legislative Correspondent and Constituent Services Representative, Sen. Tom Carper (D-DE) |
| MICHAELA SIMS | Legislative Counsel, Sen. Ben Nelson (D-NE); Legislative Director and Counsel, Sen. Bob Kerrey (D-NE) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.